Company Search:
Advanced Search
Sponsored Links
Bioxyne Limited Company Snapshot
Bioxyne Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other companies in this sector in AUSTRALIA : Exopharm Ltd (2020 sales of 2.67 million Australian Dollars [US$2.06 million] ), Lbt Innovations Limited (1.75 million Australian Dollars [US$1.35 million] of which 100% was ommercialising innovative technologie), and Oncosil Medical Ltd (2.87 million Australian Dollars [US$2.21 million] of which 100% was Medical Treatments).

Sales Analysis. During the second fiscal quarter of 2021, sales at Bioxyne Limited totalled A$1.21 million. This is a drop of 10.4% from the A$1.35 million in sales at the company during the second quarter in 2020. During the year ended June of 2020, sales at Bioxyne Limited were A$2.26 million (US$1.74 million). This is an increase of 5.9% versus 2019, when the company's sales were A$2.13 million. This was the third consecutive year of growth at Bioxyne Limited.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bioxyne Limited
  Stock Performance Chart for Bioxyne Limited
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): .02
(Figures in Australian Dollars)
1 Week 15.8%   13 Weeks 0.0%  
4 Weeks 100.0%   52 Weeks 120.0%  
Bioxyne Limited Key Data:
  Ticker: BXN Country: Australia
  Exchanges: BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 2,259,264
(Year Ending Jan 2021).
Employees: 16
  Currency: Australian Dollars Market Cap: 14,083,199
  Fiscal Yr Ends: June Shares Outstanding: 640,145,398
  Share Type: Ordinary Closely Held Shares: 420,247,892
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.